LC-ESI-MS determination of bilobalide and ginkgolides in canine plasma

被引:12
作者
Tang, JL [1 ]
Sun, J [1 ]
Sun, YH [1 ]
Cui, FD [1 ]
He, ZG [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Dept Biopharmaceut, Shenyang 110016, Peoples R China
关键词
column liquid chromatography; LC-ESI-MS; pharmacokinetics; bilabolide and ginkgolides in canine plasma;
D O I
10.1365/s10337-005-0671-z
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A sensitive and selective method using liquid chromatography with electrospray ionization mass spectrometric detection was developed for the quantification of bilobalide and ginkgolides in canine plasma. The analytes were extracted with diethyl ether-dichloromethane-isopropanol (6:3:1, v/v) after spiking the samples with daidzein (internal standard). The lower limit of quantification (LLOQ) of the method was 2.5 mu g L-1 for ginkgolide B and 10.0 mu g L-1 for bilabolide, ginkgolide A and ginkgolide C. The accuracy of the method was within 15% of the actual values over a wide range of plasma concentrations. The intra-day and inter-day precision was better than 15% (R.S.D.). Finally, the LC-ESI-MS method was successfully applied to study the pharmacokinetics of ginkgolides and bilabolide after administration of Ginkgo biloba extracts to dogs.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 9 条
[1]
Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS [J].
Biber, A ;
Koch, E .
PLANTA MEDICA, 1999, 65 (02) :192-193
[2]
DeFeudis F. V., 2000, Current Drug Targets, V1, P25, DOI 10.2174/1389450003349380
[3]
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors [J].
Huang, SH ;
Duke, RK ;
Chebib, M ;
Sasaki, K ;
Wada, K ;
Johnston, GAR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) :131-138
[4]
Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations [J].
Kressmann, S ;
Biber, A ;
Wonnemann, M ;
Schug, B ;
Blume, HH ;
Müller, WE .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (11) :1507-1514
[5]
The bioavailability of ginkgolides in Ginkgo biloba extracts [J].
Li, CL ;
Wong, YY .
PLANTA MEDICA, 1997, 63 (06) :563-565
[6]
The CNS effects of Ginkgo biloba extracts and ginkgolide B [J].
Maclennan, KM ;
Darlington, CL ;
Smith, PE .
PROGRESS IN NEUROBIOLOGY, 2002, 67 (03) :235-257
[7]
Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts [J].
Mauri, P ;
Simonetti, P ;
Gardana, C ;
Minoggio, M ;
Morazzoni, P ;
Bombardelli, E ;
Pietta, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (12) :929-934
[8]
Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of terpene lactones in plasma of animals [J].
Mauri, P ;
Minoggio, M ;
Iemoli, L ;
Rossoni, G ;
Morazzoni, P ;
Bombardelli, E ;
Pietta, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (4-5) :633-639
[9]
Preparation of 7-substituted ginkgolide derivatives: Potent platelet activating factor (PAF) receptor antagonists [J].
Vogensen, SB ;
Stromgaard, K ;
Shindou, H ;
Jaracz, S ;
Suehiro, M ;
Ishii, S ;
Shimizu, T ;
Nakanishi, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) :601-608